Case Reports in Oncology最新文献

筛选
英文 中文
Early Screening and Identification of an Asymptomatic Pheochromocytoma in a Child with Von Hippel-Lindau: A Case Report. Von Hippel-Lindau 儿童无症状嗜铬细胞瘤的早期筛查和识别:病例报告。
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.1159/000541527
Kristine Schmeling, Jennifer Schuh, Dave Lal, Kerri Becktell
{"title":"Early Screening and Identification of an Asymptomatic Pheochromocytoma in a Child with Von Hippel-Lindau: A Case Report.","authors":"Kristine Schmeling, Jennifer Schuh, Dave Lal, Kerri Becktell","doi":"10.1159/000541527","DOIUrl":"10.1159/000541527","url":null,"abstract":"<p><strong>Introduction: </strong>Von Hippel-Lindau (VHL) is a diagnosis that leads to increased risk of tumor development over the course of a patient's lifetime. Patients with VHL undergo screening for multiple tumor types, including pheochromocytomas (PCCs). There is variability among the different international guidelines regarding the age to begin PCC screening, with most suggesting 5 years for screening initiation.</p><p><strong>Case presentation: </strong>Our patient is a 4-year-old female who underwent screening for PCC at the time of her VHL diagnosis while asymptomatic that identified a unilateral PCC. This was amendable to treatment with laparoscopic partial adrenalectomy.</p><p><strong>Conclusion: </strong>This is the first report of an asymptomatic PCC being identified in a patient under the age of 5. With early identification, this was treated surgically before it caused systemic symptoms with preservation of normal adrenal gland tissue. This supports adhering to the pediatric specific guidelines which recommend earlier initiation of PCC screening in pediatric patients with VHL.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1309-1315"},"PeriodicalIF":0.7,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11563656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basosquamous Carcinoma Arising from the Vulva: A Case Report. 外阴基底鳞状上皮癌:病例报告。
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1159/000541967
Fatma Saadallah, Ayoub Ghazouani, Ines Zemni, Haykel Turki, Houyem Mansouri, Ghada Sahraoui, Tarek Ben Dhiab
{"title":"Basosquamous Carcinoma Arising from the Vulva: A Case Report.","authors":"Fatma Saadallah, Ayoub Ghazouani, Ines Zemni, Haykel Turki, Houyem Mansouri, Ghada Sahraoui, Tarek Ben Dhiab","doi":"10.1159/000541967","DOIUrl":"https://doi.org/10.1159/000541967","url":null,"abstract":"<p><strong>Introduction: </strong>Basosquamous carcinoma (BSC) of the vulva is an uncommon tumor that primarily consists of basal cell carcinoma with squamous differentiation. Also known as metatypical basal cell carcinoma, BSC is typically classified as a skin cancer and represents only 2% of non-melanoma skin malignancies. This type of carcinoma has a poorer prognosis than basal cell carcinoma due to its increased local aggressiveness and metastatic potential.</p><p><strong>Case presentation: </strong>We present the case of a 59-year-old woman with a 3-year history of a slow-growing and painful vulvar lesion. Clinical examination revealed a 35-mm nodular, ulcerating, and non-pigmented lesion located on the labia majora. A biopsy confirmed the diagnosis of BSC, and staging assessments indicated no evidence of metastasis. The patient underwent partial radical vulvectomy and sentinel lymph node biopsy, with histological analysis revealing distinct features characteristic of BSC, including basaloid cell islands and areas of significant squamous differentiation. The excision margins were tumor-free, and all six lymph nodes examined were negative for metastases. Regular surveillance for 6 months was conducted without signs of recurrence.</p><p><strong>Conclusion: </strong>After reviewing the literature, this case represents the sixth documented instance of vulvar BSC. Compared to basal cell carcinoma, BSC has a poorer prognosis, with a higher potential for recurrences and metastases. While basal cell carcinoma is much more prevalent among vulvar and skin malignancies, recognizing the squamous differentiation component is crucial for ensuring wider margins during surgical excision.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1282-1288"},"PeriodicalIF":0.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External Beam Radiotherapy for Malignant Central Airway Obstruction in a Remote Rural Patient: A Case Study. 偏远农村患者恶性中央气道阻塞的体外放射治疗:病例研究。
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1159/000542104
Eoin Collins, Druva Mitra, Scott Carruthers
{"title":"External Beam Radiotherapy for Malignant Central Airway Obstruction in a Remote Rural Patient: A Case Study.","authors":"Eoin Collins, Druva Mitra, Scott Carruthers","doi":"10.1159/000542104","DOIUrl":"https://doi.org/10.1159/000542104","url":null,"abstract":"<p><strong>Introduction: </strong>Malignant central airway obstruction (MCAO) is a challenging therapeutic scenario, caused by tumour burden which limits airflow within the large airways. Squamous cell carcinoma (SCC) of the lung accounts for 50% of MCAO seen in the setting of non-small cell lung cancer. Here, we present the challenging case of a 63-year-old Indigenous Australian Female rom a remote rural community with background history of metastatic SCC of presumed pulmonary origin, who presented with a 1-week history of dyspnoea, stridor, and hoarse voice.</p><p><strong>Case presentation: </strong>A CT chest and neck demonstrated a superior mediastinal mass compressing the trachea to a narrowest diameter of 3 mm. The patient was stabilised in her local health centre, then transferred to our tertiary care facility for further evaluation and management. This stenotic lesion was not amenable to bronchoscopic or surgical intervention but was instead treated successfully with a short course of external beam radiotherapy, to total dose of 25Gy delivered over 10 fractions. The patient had almost complete resolution of respiratory symptoms with no significant radiotherapy related toxicity.</p><p><strong>Conclusion: </strong>Here, we discuss a challenging case of MCAO in a remote rural Australian patient and demonstrate the utility of external beam radiotherapy in this setting. We also discuss aspects of cancer related healthcare disparities which exist for Indigenous Australians. In doing so, we wish to highlight the need for improved cancer healthcare for such communities.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1301-1308"},"PeriodicalIF":0.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Grade Sarcoma of the Pulmonary Artery That Mimicked a Pulmonary Embolism in a 39-Year-Old Patient with Recurrent Miscarriages: A Case Report. 一名 39 岁反复流产患者的肺动脉高级别肉瘤模仿肺栓塞:病例报告。
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1159/000542052
John Corbyn Cravero, Laith Wahab, Dirk T Wilson, Ali Alani, Arthur Bredeweg, Roberto Aguirre
{"title":"High-Grade Sarcoma of the Pulmonary Artery That Mimicked a Pulmonary Embolism in a 39-Year-Old Patient with Recurrent Miscarriages: A Case Report.","authors":"John Corbyn Cravero, Laith Wahab, Dirk T Wilson, Ali Alani, Arthur Bredeweg, Roberto Aguirre","doi":"10.1159/000542052","DOIUrl":"https://doi.org/10.1159/000542052","url":null,"abstract":"<p><strong>Introduction: </strong>Primary pulmonary artery sarcoma is a rare malignancy with a poor prognosis, undefined treatment guidelines, and is often mistaken for a pulmonary embolism (PE) based on similar clinical presentation and radiographic findings.</p><p><strong>Case presentation: </strong>We present a case of a 39-year-old female with a past medical history of recurrent miscarriages who presented with a chief complaint of dyspnea. Due to a history of recurrent miscarriages, a predisposing coagulopathic condition was suspected for a PE. A V/Q scan showed high probability for a PE with bilateral perfusion defects. Subsequent CT angiographic imaging of the chest was read as positive for a massive PE. The patient was transferred to the medical ICU for tPA administration but developed worsening hypoxic respiratory failure and was transferred to an outside hospital for expert surgical consultation and thrombectomy. Intraoperative reports during thrombectomy commented on a mass within the pulmonary artery. Subsequent pathology showed a high-grade sarcoma. The patient was started on adjuvant chemotherapy with doxorubicin, ifosfamide, and MESNA; however, due to multiple comorbidities, the patient ultimately succumbed to her illness.</p><p><strong>Conclusion: </strong>This case underscores the diagnostic difficulty in distinguishing pulmonary artery sarcomas from a PE, especially in the presence of other confounders and biases.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1294-1300"},"PeriodicalIF":0.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Patterns of Platelet Count Fluctuation in Response to Various Anticancer Chemotherapies among Patient with Bladder Cancer. 膀胱癌患者在接受各种抗癌化疗时血小板计数的不同波动模式
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1159/000541679
Ayako Watanabe, Yu Ogawa, Misa Saeki, Takuya Nagata, Masashi Morita, Kenji Momo
{"title":"Different Patterns of Platelet Count Fluctuation in Response to Various Anticancer Chemotherapies among Patient with Bladder Cancer.","authors":"Ayako Watanabe, Yu Ogawa, Misa Saeki, Takuya Nagata, Masashi Morita, Kenji Momo","doi":"10.1159/000541679","DOIUrl":"https://doi.org/10.1159/000541679","url":null,"abstract":"<p><strong>Introduction: </strong>In general, platelet counts fluctuate in cancer patients receiving anticancer therapy. It may include thrombocytopenia caused by bone marrow suppression due to cytotoxic anticancer agents and thrombocytosis due to rebound during recovery. This should not be the case in the case of administration of immune checkpoint inhibitors, given their mechanism of action.</p><p><strong>Case presentation: </strong>However, we have experienced a case of thrombocytosis in a patient treated with an immune checkpoint inhibitor. We present a platelet count pattern in patient with bladder cancer underwent Gemcitabine and Cisplatin (GC) therapy and pembrolizumab monotherapy.</p><p><strong>Conclusion: </strong>This case underscores the need for a diverse perspective on platelet behavior in clinical settings.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1277-1281"},"PeriodicalIF":0.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142615555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polyradiculitis as a Neurological Complication Associated with Adagrasib: A Case Report. 与阿达拉西布有关的神经系统并发症--多发性神经炎:病例报告。
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.1159/000541988
Kristofoor E Leeuwenberg, Rob Ter Heine, Johanna M M Gijtenbeek, Michel M van den Heuvel
{"title":"Polyradiculitis as a Neurological Complication Associated with Adagrasib: A Case Report.","authors":"Kristofoor E Leeuwenberg, Rob Ter Heine, Johanna M M Gijtenbeek, Michel M van den Heuvel","doi":"10.1159/000541988","DOIUrl":"https://doi.org/10.1159/000541988","url":null,"abstract":"<p><strong>Introduction: </strong>Adagrasib is an upcoming anticancer treatment for KRAS G12C-mutated non-small-cell lung carcinoma, colorectal cancer and potentially other solid tumors harboring this mutation. It is generally well-tolerated and reports of neurological adverse events so far have been limited.</p><p><strong>Case presentation: </strong>We present to our best knowledge the first case of a 70-year-old woman who was admitted with polyradiculitis as a treatment-related complication of adagrasib. Symptoms resolved after treatment with prednisone and therapy interruption of adagrasib followed by a permanent dose reduction. After the dose reduction, there was an ongoing effective tumor response at follow-up, and serum concentrations of adagrasib remained within the therapeutic index.</p><p><strong>Conclusion: </strong>Through this case report, we aim to bring attention to the possibility of this side effect, as we believe it is important to be aware of it for future patients undergoing treatment with adagrasib.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1289-1293"},"PeriodicalIF":0.7,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142635894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report. SARS-CoV-2诱导化疗耐药B细胞非霍奇金淋巴瘤缓解:病例报告
IF 0.7
Case Reports in Oncology Pub Date : 2024-11-07 eCollection Date: 2024-01-01 DOI: 10.1159/000541964
Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang
{"title":"SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report.","authors":"Yan Xiao, Jinwei Wang, Kai Yang, Meiling Jiang, Bo Zhang","doi":"10.1159/000541964","DOIUrl":"https://doi.org/10.1159/000541964","url":null,"abstract":"<p><strong>Introduction: </strong>Investigation on virus-host interaction may provide new clues for antitumor immunotherapy.</p><p><strong>Case presentation: </strong>In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission.</p><p><strong>Conclusion: </strong>Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1273-1276"},"PeriodicalIF":0.7,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142603344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteosarcoma Arising from Iliac Bone Lesions of Hereditary Multiple Osteochondromas: A Case Report. 遗传性多发性骨软骨瘤髂骨病变引发的骨肉瘤:病例报告。
IF 0.7
Case Reports in Oncology Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.1159/000541480
Tadamasa Handa, Kunihiro Asanuma, Hiroto Yuasa, Tomoki Nakamura, Tomohito Hagi, Katsunori Uchida, Akihiro Sudo
{"title":"Osteosarcoma Arising from Iliac Bone Lesions of Hereditary Multiple Osteochondromas: A Case Report.","authors":"Tadamasa Handa, Kunihiro Asanuma, Hiroto Yuasa, Tomoki Nakamura, Tomohito Hagi, Katsunori Uchida, Akihiro Sudo","doi":"10.1159/000541480","DOIUrl":"10.1159/000541480","url":null,"abstract":"<p><strong>Introduction: </strong>Osteochondromas are benign tumors that arise primarily in the metaphyseal region of long bones. The malignant transformation rate is estimated to be less than 1% and 1-3% in solitary and multiple osteochondromas, respectively. Transformation to osteosarcoma is very rare. Little information is available on treatment or outcome. A rare case of osteosarcoma arising from hereditary multiple osteochondromas of the right iliac bone is reported.</p><p><strong>Case presentation: </strong>A 66-year-old woman presented with recurrent right abdominal pain. Computed tomography (CT) showed a mass protruding into the pelvic cavity, 9 cm × 7 cm × 7 cm, with bone destruction and internal calcification in the right iliac bone. A CT-guided biopsy was performed, and the diagnosis was osteosarcoma. After one course of chemotherapy with doxorubicin and ifosfamide, extensive resection of the tumor was performed. The pathology showed proliferation of highly pleomorphic dysplastic cells with bone formation inside the tumor just below the osteochondroma tissue, which led to the diagnosis of osteosarcoma arising from the osteochondroma. Three years after surgery, there was no evidence of recurrence or metastasis, and the patient was able to walk unassisted.</p><p><strong>Conclusion: </strong>A case of osteosarcoma arising from an iliac lesion of hereditary multiple osteochondromas was described. Although no recurrence or metastasis has been observed 3 years after surgery, further follow-up is necessary due to the short time after surgery.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1266-1272"},"PeriodicalIF":0.7,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed and Long-Lasting Response to 177Lu-DOTATATE in a Head and Neck Paraganglioma: Case Report and Literature Review. 头颈部副神经节瘤对 177Lu-DOTATATE 的延迟和持久反应:病例报告和文献综述。
IF 0.7
Case Reports in Oncology Pub Date : 2024-10-30 eCollection Date: 2024-01-01 DOI: 10.1159/000541359
Sofía Ruffini Egea, Sara Elena Campos Ramírez, Natalia Pilar Pascual de la Fuente, María Luna Monreal Cepero, Fatima Mocha Campillo, Pablo Trincado Cobos, Antonio Antón Torres, Javier Martínez Trufero
{"title":"Delayed and Long-Lasting Response to 177Lu-DOTATATE in a Head and Neck Paraganglioma: Case Report and Literature Review.","authors":"Sofía Ruffini Egea, Sara Elena Campos Ramírez, Natalia Pilar Pascual de la Fuente, María Luna Monreal Cepero, Fatima Mocha Campillo, Pablo Trincado Cobos, Antonio Antón Torres, Javier Martínez Trufero","doi":"10.1159/000541359","DOIUrl":"10.1159/000541359","url":null,"abstract":"<p><strong>Introduction: </strong>Malignant paragangliomas (M-PGL) are a group of neuroendocrine tumors that originate from chromaffin cells. The most common location for PGL is the head and neck, which comprise 65-70% of all PGL, and the M-PGL accounts for 0.6% of all head and neck cancers. It is a rare tumor, with an incidence of 2-8 per million. Diagnosing PGL can be challenging, and treatment for metastatic disease is usually not curative.</p><p><strong>Case presentation: </strong>A 66-year-old woman was diagnosed with left cervical pain and laterocervical mass in March 2015. Octreotide scintigraphy showed intense uptake in the cervical mass, two pulmonary micronodules of 4-5 mm, and another lesion in the lumbar region (L3-L4). The final diagnosis was malignant nonsecretory PGL with adjacent tissue involvement and distant metastases. After three different treatments with minimal symptomatic improvement, 177Lu-DOTATATE was requested off-label. With a dose of 7,400 MBq until January 2018, the patient showed remarkable symptomatic pain improvement and a decrease in tumor size.</p><p><strong>Conclusion: </strong>We believe that our case report provides relevant information that can be considered in similar cases. First, the patient tripled the expected survival in such a clinical setting, and this benefit seems to rely on 177Lu-DOTATATE treatment. Second, we documented an early symptomatic response to this treatment but a long-term delayed volumetric radiographic response.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1252-1257"},"PeriodicalIF":0.7,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11524611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purpura Fulminans from Capnocytophaga canimorsus in an Immunocompromised Host. 免疫力低下的宿主死于卡氏嗜血杆菌引起的富贵性紫癜
IF 0.7
Case Reports in Oncology Pub Date : 2024-10-29 eCollection Date: 2024-01-01 DOI: 10.1159/000541338
Indumathy Varadarajan, Natalie Pham, Karen Ballen
{"title":"Purpura Fulminans from <i>Capnocytophaga canimorsus</i> in an Immunocompromised Host.","authors":"Indumathy Varadarajan, Natalie Pham, Karen Ballen","doi":"10.1159/000541338","DOIUrl":"https://doi.org/10.1159/000541338","url":null,"abstract":"<p><strong>Introduction: </strong>Purpura fulminans is a rare but fatal manifestation of <i>Capnocytophaga canimorsus</i> bacteremia that can present in immunocompromised hosts. This can have a profound impact on patients, including recipients of allogeneic hematopoietic stem cell transplant. Despite aggressive therapy, mortality can be as high as 60% and most patients require amputation of multiple extremities.</p><p><strong>Case presentation: </strong>We present a 31-year-old woman s/p myeloablative allogeneic transplant, presenting with purpura fulminans and septic shock. She had been on Immunosuppressive therapy with rituximab and tacrolimus. Despite aggressive antibiotic coverage and supportive therapy, although her shock was resuscitated, she had to undergo bilateral below-knee amputations.</p><p><strong>Discussion: </strong>We attempt to highlight the clinical presentation, pathophysiology and potential therapeutic options for immunocompromised patients presenting with septic shock from <i>C. canimorsus</i>. The importance of pre-transplant counselling on handling and adoption of new pets to prevent zoonotic infections is also discussed. Early recognition and initiation of antibiotics play a crucial role to reduce mortality in patients receiving HSCT.</p>","PeriodicalId":9625,"journal":{"name":"Case Reports in Oncology","volume":"17 1","pages":"1246-1251"},"PeriodicalIF":0.7,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信